#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Aplastic anaemia Homocystinuria Arterial disorder Basal cell naevus syndrome Chondrosarcoma Biliary cancer metastatic Gastroenteropancreatic neuroendocrine tumour disease Osteosarcoma Oropharyngeal squamous cell carcinoma Follicular lymphoma stage II Lung adenocarcinoma Sickle cell disease Vernal keratoconjunctivitis Toxic epidermal necrolysis Neuroblastoma More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous Myelodysplastic syndrome with excess blasts – Diagnostics Myelodysplastic syndrome with excess blasts – Treatment Andersen-Tawil syndrome Nephroblastoma – Life with Disease Myelodysplastic syndrome with excess blasts – Basic Information Hereditary angioedema Primary mediastinal large B-cell lymphoma – Trials in Disease Factor VIII deficiency – Basic Information Wolfram syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Micronised Spironolactone Methylphenidate Hydrochloride Vincristine Sulfate 89ZR-CED88004S Microcrystalline Cellulose Ribociclib Acetylcysteine Amide Cortisone Co-Trimoxazole ANTI-GD2-800CW Selexipag Frexalimab Buclizine Hydrochloride Copper (64Cu) Chloride Nicotinamide Carbetocin Ammonium Chloride Bp Ertapenem Sodium Iopamidol Bomedemstat More therapies…

    Learn about Your Condition

    HER2 negative breast cancer Papulopustular rosacea Diabetic foot infection Pulmonary hypertension Myelofibrosis Hypochondroplasia Diabetes mellitus Diabetic nephropathy Malignant melanoma of eyelid Rectal cancer stage II Craniopharyngioma Adenocarcinoma gastric Immune system disorder Medication overuse headache Embolic stroke More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Iron deficiency anaemia
    Investigated Drugs:
    • Ferumoxytol
    • Iron Sucrose
    Lithuania Poland

  • Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dapagliflozin Propanediol
    Sweden

  • Comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children with chronic kidney disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Iron deficiency anaemia
    Investigated Drugs:
    • Ferumoxytol
    • Iron Sucrose
    Hungary Lithuania Poland

  • Study on How Metformin Affects Arterial Calcification in Patients with Type 1 Diabetes Without Chronic Kidney Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Vascular calcification
    Investigated Drugs:
    • Metformin Hydrochloride
    France

  • Study on Long-Term Safety and Pregnancy Outcomes of Pariglasgene Brecaparvovec in Patients with Glycogen Storage Disease Type Ia (GSDIa)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glycogen storage disease type I
    Investigated Drugs:
    • Pariglasgene Brecaparvovec
    Denmark Germany Italy The Netherlands Spain

  • Study on the Effects of Finerenone and SGLT2 Inhibitors on Heart and Kidney Health in Patients with Type 2 Diabetes and Chronic Kidney Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Denmark
Previous Page
1 … 13 14 15 16 17 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!